PDL BioPharma, 2.75% 1dec2021, USD (Conv.) (FIGI BBG00FBBP341, WKN A189MY)
国内債券, 転換社債, Senior Unsecured
国内債券, 転換社債, Senior Unsecured
|
PDL BioPharma (known as Protein Design Labs prior to 2006). PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery ...
PDL BioPharma (known as Protein Design Labs prior to 2006). PDL was founded in 1986 and is headquartered in Incline Village, Nevada. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue.
|
|
|
|
|
|
|
|
|
最も包括的なデータベースを探索
1 000 000
債券
100 000
株
175 910
ETF&投資信託
100 000
インデックス
最も効率的な方法でポートフォリオを追跡